Quantitative cardiac amyloid radionuclide imaging
Open Access
- 15 May 2026
- journal article
- review article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 59, 102724
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 90 references indexed in Scilit:
- Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligenceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlookEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Impact of Vutrisiran on Exploratory Cardiac Parameters in Hereditary Transthyretin-Mediated Amyloidosis with PolyneuropathyEuropean Journal of Heart Failure, 2024
- EANM practice guideline for quantitative SPECT-CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomographyAnnals of Nuclear Medicine, 2019
- Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosisJournal of Nuclear Cardiology, 2019
- Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Quantification of 11C-PIB kinetics in cardiac amyloidosisJournal of Nuclear Cardiology, 2018
- Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac ImagingJAMA Cardiology, 2016
- Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014